This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Second Primary Malignancy
Information about Second Primary Malignancy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Second Primary Malignancy
Most recent studies have shown that Second Primary Malignancy shares some biological mechanisms with adenocarcinoma, carcinoma, head-and-neck-neoplasms, hodgkin-disease, leukemia, lung-neoplasms, lymphoma, malignant-neoplasm-of-breast, malignant-neoplasm-of-lung, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, mammary-neoplasms, melanoma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neoplasms-multiple-primary, neoplasms-radiation-induced, neoplasms-second-primary.
Among the many pathways, these few ones have gauged particular interests from scientists studying Second Primary Malignancy, and have been seen in publications frequently: Aging, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Killing, Cell Proliferation, Dna Repair, Enucleation, Hypersensitivity, Immune Response, Localization, Menarche, Menopause, Methylation, Mismatch Repair, Oncogenesis, Pathogenesis, Pigmentation, Plasminogen Activation
Quite a number of genes have been found to play important roles in Second Primary Malignancy, such as ACAT1, BRCA1, BRCA2, CALCR, CDKN2A, ERBB2, ESR1, HTT, KLK3, LYPD4, MID1, MPZ, NDUFB6, NR0B1, PMP22, POMT1, RB1, SLC25A5, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.